Drug class in one race
α4β7 integrin drugs for Crohn's Disease
2 tracked α4β7 integrin drugs in the Crohn's Disease race. The class explanation lives on the α4β7 integrin page; the full indication pipeline across every mechanism is on the Crohn's Disease page.
1 approved / phase 41 Phase 2
Head-to-head evidence: morf-057 vs vedolizumab